Your browser doesn't support javascript.
loading
Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients.
Zhu, Ming-Yu; Chen, Pei-Zhan; Li, Jing; Yu, De-Min; Huang, Dao; Zhu, Xue-Juan; Han, Yue; Chen, Jie; Huang, Wei; Chen, Yong-Yan; Gong, Qi-Ming; Jiang, Jie-Hong; Zhang, Dong-Hua; Zhang, Yan; Zhang, Ji-Ming; Zhang, Xin-Xin.
Afiliação
  • Zhu MY; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Chen PZ; Translational Medicine Research Center, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Li J; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Yu DM; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Huang D; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhu XJ; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Han Y; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Chen J; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Huang W; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Chen YY; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Gong QM; Department of Infectious Diseases, Institute of Infectious and Respiratory Diseases, Ruijin Hospital, School of Medicine Shanghai Jiao Tong University, Shanghai, China.
  • Jiang JH; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang DH; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang Y; Ministry of Education Key Laboratory of Systems Biomedicine, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang JM; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhang XX; Clinical Virology Research Laboratory, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
J Med Virol ; 90(4): 721-729, 2018 04.
Article em En | MEDLINE | ID: mdl-29247529
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Glicoproteínas de Membrana / Biomarcadores / Interferon-alfa / Hepatite B Crônica / Antígenos de Neoplasias Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Med Virol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Glicoproteínas de Membrana / Biomarcadores / Interferon-alfa / Hepatite B Crônica / Antígenos de Neoplasias Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Med Virol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos